Drug therapy
Safe living strategies for the immunocompromised child
Posted: Jun 21, 2019
Committee(s): Infectious Diseases and Immunization Committee
Topic(s): immunization, patient safety, drug therapy, respirology, sexual health
Invasive group A streptococcal disease: Management and chemoprophylaxis
Posted: Apr 15, 2019
Committee(s): Infectious Diseases and Immunization Committee
Topic(s): drug therapy, infectious diseases
HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures
Posted: Feb 15, 2019
Committee(s): Infectious Diseases and Immunization Committee
Topic(s): infectious diseases, breastfeeding, fetal and maternal issues, newborn medicine, sexual health, social paediatrics, drug therapy
Emergency department use of oral ondansetron for acute gastroenteritis-related vomiting in infants and children
Posted: Dec 19, 2018
Committee(s): Acute Care Committee
Topic(s): drug therapy, emergency medicine, acute care, nutrition and gastroenterology
Approaches to detecting tuberculosis in children and youth
Posted: Dec 14, 2018
Committee(s): Infectious Diseases and Immunization Committee
Topic(s): infectious diseases, social paediatrics, Indigenous health, drug therapy
Salmonella infections in Canadian children
Posted: Dec 3, 2018
Committee(s): Infectious Diseases and Immunization Committee
Topic(s): drug therapy, infectious diseases, community paediatrics
Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management
Posted: Oct 31, 2018
Committee(s): Infectious Diseases and Immunization Committee
Topic(s): drug therapy, hospital paediatrics, infectious diseases, respirology
Diagnosis and management of typical, newly diagnosed primary immune thrombocytopenia (ITP) of childhood
Posted: Oct 26, 2018
Committee(s): Acute Care Committee
Topic(s): infectious diseases, drug therapy, hospital paediatrics, acute care
ADHD in children and youth: Part 2—Treatment
Posted: Oct 24, 2018 | Reaffirmed: Jan 11, 2024
Committee(s): Mental Health and Developmental Disabilities Committee
Topic(s): drug therapy, adhd, developmental paediatrics
ADHD in children and youth: Part 3—Assessment and treatment with comorbid ASD, ID, or prematurity
Posted: Oct 24, 2018 | Reaffirmed: Jan 11, 2024
Committee(s): Mental Health and Developmental Disabilities Committee
Topic(s): autism, adhd, developmental paediatrics, mental health, drug therapy, genetics
Disclaimer: The recommendations in this position statement do not indicate an exclusive course of treatment or procedure to be followed. Variations, taking into account individual circumstances, may be appropriate. Internet addresses are current at time of publication.